Internal Medicine, Hematology & Oncology · Cincinnati, OH
NPI
1750378717
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
234 Goodman St
Cincinnati, OH, 45219
Phone (513) 475-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,078 services
Medicare patients, 2024
277
Average age 72
Drug cost, 2024
$5.3M
663 prescriptions
Company payments, 2025
$216
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tahir Latif was code 99233 (hospital e&m - subsequent), 219 times for 43 patients. In total Tahir Latif billed 1,078 services in 16 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 219 | 43 | $88.11 | $19K |
| 99214 Office E&M - Established | Facility | 190 | 89 | $65.27 | $12K |
| 99215 Office E&M - Established | Facility | 157 | 76 | $105.30 | $17K |
| 99214 Office E&M - Established | Office | 133 | 85 | $65.10 | $8,658 |
| 99215 Office E&M - Established | Office | 90 | 55 | $100.36 | $9,032 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 70 | 48 | $12.49 | $874 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 36 | $12.17 | $475 |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 25 | $59.55 | $2,322 |
| 99238 Hospital Discharge Management | Facility | 31 | 25 | $60.98 | $1,890 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $127.45 | $3,059 |
| 99213 Office E&M - Established | Office | 19 | 17 | $36.63 | $696 |
| 99213 Office E&M - Established | Facility | 17 | 13 | $32.31 | $549 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $98.23 | $1,179 |
By year: 2022 $177K for 1,695 services; 2023 $77K for 977 services; 2024 $80K for 1,078 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tahir Latif prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 61 prescriptions and refills. In total Tahir Latif wrote 663 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 61 | 61 | 13 | $1.1M |
| Acyclovir Generic | 57 | 79 | 22 | $600 |
| Lenalidomide Generic | 53 | 53 | Under 11 | $721K |
| Calquence Acalabrutinib Maleate | 51 | 51 | Under 11 | $625K |
| Pomalyst Pomalidomide | 49 | 49 | Under 11 | $1.1M |
| Imbruvica Ibrutinib | 44 | 44 | Under 11 | $649K |
| Imatinib Mesylate Generic | 32 | 32 | Under 11 | $3,576 |
| Prednisone Generic | 20 | 26 | Under 11 | $83.32 |
| Jakafi Ruxolitinib Phosphate | 19 | 19 | Under 11 | $322K |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $167 |
| Promacta Eltrombopag Olamine | 14 | 14 | Under 11 | $195K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 13 | Under 11 | $51.19 |
| Zolinza Vorinostat | 13 | 13 | Under 11 | $168K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 | 12 | 11 | $90.3 |
| Famotidine Generic | 11 | 13 | Under 11 | $19.43 |
Brand drugs: - claims; generic drugs: 351 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tahir Latif $216 ($216 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sanofi US Services Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.